A Randomized Trial of a Transglutaminase 2 Inhibitor for Celiac Disease.
N Engl J Med. 2021 Jul 1;385(1):35-45. doi: 10.1056/NEJMoa2032441.
N Engl J Med. 2021.
PMID: 34192430
Clinical Trial.